Potvin’s TSDs in the EU [Two-Stage / GS Designs]

posted by Shuanghe  – Spain, 2013-10-31 11:48 (4617 d 08:37 ago) – Posting: # 11836
Views: 8,697

Hi,

❝ .. is principally acceptable. ...


When I saw this I knew something bad gonna happen. :-D

❝ ... However, as the study was stopped for inequivalence, any further considerations on type I error control become obsolete.


OK, that's not what I was expecting.

I don't know if Elmaestro and I were reading the same thing but the hidden line I've got is that:

ok, you are "lucky" that your formulation screwed so you have to stop after stage 1; if you go to stage 2 and the result "appears" OK I'm gonna ask about the alpha inflation, higher patient risk, etc etc...

How's that "... occasionally even Austrians say something meaningful. " :-D

All the best,
Shuanghe

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
133 visitors (0 registered, 133 guests [including 25 identified bots]).
Forum time: 21:25 CEST (Europe/Vienna)

Scientists cannot simply hang their subjectivities
up on a hook outside the laboratory door.    Ruth Bleier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5